COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest peer-reviewed research articles from the Eastern Mediterranean Region
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean
COVID-19 | Discover the latest publications published by WHO Regional Office for the Eastern Mediterranean

Virtual Health Sciences Library

  • Home
  • Search
  • Knowledge Base
  • Get a journal indexed in the Index Medicus
  • MyVHSL
  1. Home
  2. IMEMR
  3. Search Result
  4. The problem of bupivacaine [marcaine]

The problem of bupivacaine [marcaine]

Authors

Seed, Richard F.
Saudi Med. J. 1986; 7 (1): 1-4
Saudi Medical Journal
Journal Country: Saudi Arabia
P-ISSN: 0379-5284
E-ISSN: 1658-3175
MeSH Terms:
Broad Subjects:
Citation: Richard F. Seed, The problem of bupivacaine [marcaine]. Saudi Med. J. 1986; 7 (1): 1-4

Abstract English

The use of bupivacaine [marcaine [R] in obstetric analgesia and in i. v. regional analgesia [Bier’ block] has recently been the subjects of many articles and editorials in medical and lay press. Recommendations on the use bupivacaine have been made by some drug regulatory authorities without significant consultation. Toxic reactions can follow the use of any local anaesthetic and users of any of these drugs must recognize the warning signs of toxicity and be able to resuscitate patients adequately and properly. Bupivacaine is the drug of choice for obstetric epidural analgesia but should not be used in a concentration of greater than 0.5%. It should not be used in Bier’s block

Request full text

Subscribe to VHSL Newsletters

© 2023 WHO – EMRO